Clinical Trial Update: Ayahuasca, Esketamine and PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial at the University of Sao Paulo examining ayahuasca and esketamine for Posttraumatic Stress Disorder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Ayahuasca (ayahuasca (psychedelic brew containing N,N-dimethyltryptamine and beta-carbolines))
• Esketamine (esketamine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 2 | Status: RECRUITING